Exelixis reported $255.33M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 95.33M 14.04M
Acceleron Pharma XLRN:US $ 59.48M 9.66M
Agios Pharmaceuticals AGIO:US $ 60.65M 35.85M
Akebia Therapeutics AKBA:US $ 165.6M 7.08M
Amgen AMGN:US $ 14585M 1716M
AstraZeneca AZN:LN 22222M 709M
Bayer BAYN:GR € 27926M 1006M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 247.76M 41.45M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Cytokinetics CYTK:US $ 61.77M 25.84M
Dicerna Pharmaceuticals DRNA:US $ 207.65M 25.5M
Eisai 4523:JP Y 277934M 21917M
Eli Lilly And LLY:US $ 13682M 1411.2M
Esperion Therapeutics ESPR:US $ 82.64M 15.25M
Exelixis EXEL:US $ 255.33M 41.99M
Genmab GEN:DC DK 1351M 58M
Glaxosmithkline GSK:US $ 22417M 1030M
Immunogen IMGN:US $ 120.32M 14.03M
IONIS PHARMACEUT IONS:US $ 293.82M 1.28M
Macrogenics MGNX:US $ 69.92M 16.88M
Merk MRK:US $ 21906M 4455M
Mirati Therapeutics MRTX:US $ 180.87M 103.76M
Moderna Inc MRNA:US 8.84B 399M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Neurocrine Biosciences NBIX:US $ 212.9M 22.9M
Novartis NOVN:VX SF 29633M 527M
Puma Biotechnology PBYI:US $ 137.9M 2.51M
Seattle Genetics SGEN:US $ 433.83M 44.22M
Takeda 4502:JP Y 1644766M 128410M
Ultragenyx Pharmaceutical RARE:US $ 127.07M 0.02M
Xencor XNCR:US $ 45.96M 53.97M
YTE INCY:US $ 660.32M 36.44M